AUD 0.73
(-1.35%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | - | 333.32 Thousand | 189.48 Thousand | 202.31 Thousand | 496.06 Thousand |
Cost of Revenue | - | 1.47 Million | 912.66 Thousand | 1.41 Million | 1.64 Million |
Gross Profit | - | -1.14 Million | -723.17 Thousand | -1.21 Million | -1.14 Million |
Operating Expenses | 9.87 Million | 15.43 Million | 8.9 Million | 6.56 Million | 142.63 Thousand |
Selling, General and Administrative Expenses | 9.87 Million | - | - | - | 2.28 Million |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | - | 19.56 Thousand | - | - | - |
Cost and Expenses | - | 16.91 Million | 9.81 Million | 7.98 Million | 1.78 Million |
Operating Income | -19.76 Thousand | -16.4 Million | -9.62 Million | -8.88 Million | -4.93 Million |
Interest Expense | - | 1.68 Million | - | - | - |
Income Tax Expense | - | 1.7 Million | - | -144.75 Thousand | - |
Earnings before Tax | -9728.66 | -18.09 Million | -11.24 Million | -7.8 Million | -1.27 Million |
Net Income | -9728.66 | -18.09 Million | -11.24 Million | -7.65 Million | -1.27 Million |
Earnings Per Share Basic | -0.00 | -0.08 | -0.09 | -0.03 | -0.01 |
Earnings Per Share Diluted | -0.00 | -0.08 | -0.09 | -0.03 | -0.01 |
Weighted Average Shares Outstanding | 160.01 Million | 241 Million | 122.24 Million | 241 Million | 241 Million |
Weighted Average Shares Outstanding (Diluted) | 160.01 Million | 240.98 Million | 122.24 Million | 240.98 Million | 240.98 Million |
Gross Margin | - | -3.43 | -3.82 | -5.98 | -2.32 |
EBIT Margin | - | -48.77 | -29.27 | -43.45 | -9.82 |
Profit Margin | - | -54.28 | -59.32 | -37.85 | -2.58 |
EBITDA | -9865.77 | -16.25 Million | -5545.91 | -8790.89 | -4872.72 |
Earnings Before Tax Margin | - | -49.21 | -50.82 | -43.93 | -9.96 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | -1784.07 | - | 9.87 Million | 1.37 Million | 1.37 Million | 3.56 Million |
Selling, General and Administrative Expenses | - | - | - | - | - | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -1784.07 | - | - | - | - | - |
Cost and Expenses | -1784.07 | - | 9.87 Million | 1.37 Million | 1.37 Million | 3.56 Million |
Operating Income | -1784.07 | -1784.07 | -9.88 Million | -1.37 Million | -1.37 Million | -3.56 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | -1784.07 | -1784.07 | - | -1371.93 | - | - |
Earnings before Tax | -1748.28 | -1748.28 | -9.72 Million | -1319.77 | -1.31 Million | -3.54 Million |
Net Income | -1748.28 | -1748.28 | -9.72 Million | -1319.77 | -1.31 Million | -3.54 Million |
Earnings Per Share Basic | - | -0.01 | - | -0.01 | -0.01 | -0.04 |
Earnings Per Share Diluted | - | -0.01 | - | -0.01 | -0.01 | -0.04 |
Weighted Average Shares Outstanding | 172.97 Million | 172.97 Million | 160.01 Million | 241 Million | 241 Million | 78.76 Million |
Weighted Average Shares Outstanding (Diluted) | 172.96 Million | 172.96 Million | 160.01 Million | 240.98 Million | 240.98 Million | 79.04 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -1779.64 | -1779.64 | - | -1367.48 | -1.36 Million | -3.56 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
SRV1V
CARE
CDI
SWZCF
BSPA
372170